Cost-effectiveness analysis and cost-utility analysis of a model of integrated mental health video consultations (PROVIDE-C randomised controlled trial) for people with depression and anxiety.
Markus Vomhof, Deborah van Eickels, Justus Tönnies et al.
✦ AI-curated · Sources linked
In 30 seconds
This study evaluated the cost-effectiveness of integrated mental health video consultations (PROVIDE-C) for individuals with depression and anxiety in primary care in Germany, compared to treatment as usual (TAU). Conducted as a randomized controlled trial with 376 participants, the results indicated that PROVIDE-C became likely cost-effective at 12 months, with a probability of cost-effectiveness of approximately 86% at a willingness-to-pay threshold of €100,000.
Key findings
- €3662 is needed for an additional person to achieve a clinically significant reduction in PHQ-ADS at 6 months.
- At 12 months, PROVIDE-C was dominant compared to TAU.
- The probability of cost-effectiveness at 12 months was approximately 86% at a €100,000 threshold.
Why it matters
Understanding the cost-effectiveness of mental health interventions is crucial for resource allocation in healthcare. This study provides evidence that integrated video consultations can be a viable option for managing depression and anxiety in primary care settings over time.